What is Innospec's increase decrease in receivables?

Innospec (IOSP) reported increase decrease in receivables of $13.7M in Q1 2026.

How has Innospec's increase decrease in receivables changed year-over-year?

Innospec's increase decrease in receivables increased by 307.6% year-over-year, from -$6.6M to $13.7M.

Innospec IOSP Increase Decrease In Receivables

Increase Decrease In Receivables at other companies

AbCellera Biologics Inc.ABCL

-$13.1M-1,256%

ICF InternationalICFI

$2.85M+113%

V2XVVX

$90.7M+1,495%

BioCryst PharmaceuticalsBCRX

$474K-96.6%

Lithium AmericasLAC

$585K+760%

Schneider NationalSNDR

$59.9M+558%

Other financials

Income statement

See full

Revenue$453.2M+2.8%

Gross profit$123.5M-1.3%

Operating income$36.5M-14.1%

Net income$30.4M-7.3%

EPS (diluted)$1.22-6.9%

Balance sheet

See full

Cash & equivalents$289.1M-3.6%

Total debt$50.6M+14.0%

Total equity$1.3B+6.7%

Total assets$1.8B+2.5%

Cash flow

See full

Operating cash flow$17.6M-37.8%

CapEx$8.9M+6.0%

Free cash flow$8.7M-56.3%

Valuation

See full

Market cap$2.05B-23.6%

Profitability

See full

Gross margin27.4%-1.3pp

Operating margin6.9%-2.6pp

Net margin6.4%—

FCF margin4.5%-1.1pp

Returns & leverage

See full

Return on equity8.8%—

Debt / equity0×0.0×

Current ratio3×+0.3×

Where this comes from

Reported directly by Innospec in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInReceivables.

The official record: Innospec’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innospec's increase decrease in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Innospec's increase decrease in receivables?: Innospec (IOSP) reported increase decrease in receivables of $13.7M in Q1 2026.
How has Innospec's increase decrease in receivables changed year-over-year?: Innospec's increase decrease in receivables increased by 307.6% year-over-year, from -$6.6M to $13.7M.